-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Agile Therapeutics Inc annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q1 2022.
- Agile Therapeutics Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was -$4.68M.
- Agile Therapeutics Inc annual Income Tax Expense (Benefit) for 2022 was -$4.68M.
- Agile Therapeutics Inc annual Income Tax Expense (Benefit) for 2018 was -$477K.
- Agile Therapeutics Inc annual Income Tax Expense (Benefit) for 2016 was -$3.08M, a 48.5% increase from 2015.
Income Tax Expense (Benefit), Quarterly (USD)